TEHRAN UNIVERSITY OF MEDICAL SCIENCES
🇮🇷Iran
- Country
- 🇮🇷Iran
- Ownership
- Private
- Established
- 1934-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.tums.ac.ir
The Effects of Fenugreek Extract (Fenobet) on Metabolic Syndrome
Not Applicable
Not yet recruiting
- Conditions
- Diabetes Mellitus, Type 2Metabolic SyndromeComplementary Therapies
- First Posted Date
- 2023-11-02
- Last Posted Date
- 2023-11-02
- Lead Sponsor
- Tehran University of Medical Sciences
- Target Recruit Count
- 60
- Registration Number
- NCT06114134
Efficacy of Oral Acetazolamide in Decongestion in Patients With Heart Failure
Phase 3
Not yet recruiting
- Conditions
- Heart Failure
- First Posted Date
- 2023-07-11
- Last Posted Date
- 2023-08-01
- Lead Sponsor
- Tehran University of Medical Sciences
- Target Recruit Count
- 130
- Registration Number
- NCT05940220
- Locations
- 🇮🇷
Houshang bavandpour karvane, Tehran, Tehran Heart Center, Iran, Islamic Republic of
Comparison of the Clinical Response of Total Neoadjuvant Treatment of Two Methods of Long-term or Short-term Chemoradiotherapy in Rectal Cancer
Not Applicable
Not yet recruiting
- Conditions
- Locally Advanced Rectal Carcinoma
- First Posted Date
- 2023-06-27
- Last Posted Date
- 2023-06-27
- Lead Sponsor
- Tehran University of Medical Sciences
- Target Recruit Count
- 114
- Registration Number
- NCT05920928
Assessment of the Efficacy of Letrozole in the Treatment of Ectopic Pregnancy
Phase 1
Active, not recruiting
- Conditions
- Ectopic Pregnancy
- Interventions
- First Posted Date
- 2023-06-26
- Last Posted Date
- 2024-03-26
- Lead Sponsor
- Tehran University of Medical Sciences
- Target Recruit Count
- 150
- Registration Number
- NCT05918718
- Locations
- 🇮🇷
Imam Khomeini Hospital Complex, Tehran, Iran, Islamic Republic of
Co-transplantation of Mesenchymal Stem Cell Derived Exosomes and Autologous Mitochondria for Patients Candidate for CABG Surgery
Phase 1
Recruiting
- Conditions
- Myocardial IschemiaMyocardial InfarctionMyocardial Stunning
- First Posted Date
- 2022-12-30
- Last Posted Date
- 2022-12-30
- Lead Sponsor
- Tehran University of Medical Sciences
- Target Recruit Count
- 20
- Registration Number
- NCT05669144
- Locations
- 🇮🇷
Tehran University of Medical Sciences, Tehran, Iran, Islamic Republic of
Safety of Injection of Placental Mesenchymal Stem Cell Derived Exosomes for Treatment of Resistant Perianal Fistula in Crohn's Patients
Phase 1
- Conditions
- Perianal Fistula in Patients With Crohn's Disease
- First Posted Date
- 2022-08-12
- Last Posted Date
- 2022-08-12
- Lead Sponsor
- Tehran University of Medical Sciences
- Target Recruit Count
- 80
- Registration Number
- NCT05499156
- Locations
- 🇮🇷
Division of Colorectal Surgery, Department of Surgery, Tehran University of Medical Sciences, Tehran, Iran, Tehran, Iran, Islamic Republic of
The Efficacy of Exercise Therapy in Patients With Inflammatory Bowel Disease
Not Applicable
- Conditions
- SarcopeniaInflammatory Bowel Diseases
- First Posted Date
- 2022-07-13
- Last Posted Date
- 2022-07-13
- Lead Sponsor
- Tehran University of Medical Sciences
- Target Recruit Count
- 56
- Registration Number
- NCT05455762
- Locations
- 🇮🇷
Imam Khomeini Hospital Complex, Tehran, Iran, Islamic Republic of
Safety and Efficacy of Injection of Human Placenta Mesenchymal Stem Cells Derived Exosomes for Treatment of Complex Anal Fistula
Phase 1
Recruiting
- Conditions
- Fistula Perianal
- First Posted Date
- 2022-06-02
- Last Posted Date
- 2022-11-02
- Lead Sponsor
- Tehran University of Medical Sciences
- Target Recruit Count
- 80
- Registration Number
- NCT05402748
- Locations
- 🇮🇷
Division of Colorectal Surgery, Department of Surgery, Tehran University of Medical Sciences, Tehran, Iran, Tehran, Iran, Islamic Republic of
Investigating the Effects of Hydroxyvitamin D3 on Multiple Sclerosis
Phase 4
- Conditions
- Adult ALLMultiple Sclerosis, Relapsing-RemittingVitamin D3 Deficiency
- First Posted Date
- 2022-04-22
- Last Posted Date
- 2022-04-22
- Lead Sponsor
- Tehran University of Medical Sciences
- Target Recruit Count
- 54
- Registration Number
- NCT05340985
GnRH Agonist Plus Hormone Replacement Therapy vs Hormone Replacement Therapy on IVF Outcomes
Phase 3
Completed
- Conditions
- Polycystic Ovary SyndromeInfertility, Female
- Interventions
- Drug: HRTDrug: Long GnRH agonist + HRT
- First Posted Date
- 2022-01-13
- Last Posted Date
- 2022-01-13
- Lead Sponsor
- Tehran University of Medical Sciences
- Target Recruit Count
- 128
- Registration Number
- NCT05189873
- Locations
- 🇮🇷
Arash women's hospital,Tehran university of medical sciences, Tehran, Iran, Islamic Republic of